Hepatic encephalopathy screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatic encephalopathy}} | {{Hepatic encephalopathy}} | ||
{{CMG}} {{AE}} | {{CMG}};{{AE}}{{MMJ}} | ||
== Overview == | == Overview == | ||
There is insufficient evidence to recommend routine screening for hepatic encephalopathy. | There is insufficient evidence to recommend routine [[screening]] for hepatic encephalopathy. | ||
== Screening == | == Screening == | ||
There is insufficient evidence to recommend routine [[screening]] for hepatic encephalopathy. | |||
== References == | == References == | ||
Latest revision as of 18:37, 24 January 2018
|
Hepatic encephalopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatic encephalopathy screening On the Web |
|
American Roentgen Ray Society Images of Hepatic encephalopathy screening |
|
Risk calculators and risk factors for Hepatic encephalopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for hepatic encephalopathy.
Screening
There is insufficient evidence to recommend routine screening for hepatic encephalopathy.